EUCTR2008-007405-37-IT进行中（未招募）不适用
Multicenter, not-for-profit study to evaluate tolerability, safety of tramadol once-a-day in older patients with dementia and difficulty to verbalize - NPTRAM1108
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2008年12月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age ≤75 years
- •A diagnosis of dementia of any type
- •Difficulty to verbalize
- •Persistent pain as testified by a score >5 at the DOLOPLUS-2 scale
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Participation to other studies in the last 3 months
- •Refuse or inability to give consent
- •Terminal state
- •On an analgesic medication for over 1 month
- •Clinical evidence suggesting an acute pain condition of any intensity
- •Contraindication to tramadol once-a-day
- •Epilepsy or current pharmacologic treatment with carbamazepine
- •Juvenile intellectual disability
- •Concomitant treatment with MAO inhibitors
- •Presence of any disease or condition which at investigators? judgment might interfere with the study
研究者
相似试验
进行中（未招募）
不适用
Multicenter, not-for-profit clinical study, in a open, controlled, randomized fashion to compare tolerability, safety and efficacy of two different treatment strategies for non malignant, persistent pain in older patients - NPTRAM0108non neoplastic cronic painMedDRA version: 9.1Level: PTClassification code 10033371Term: PainMedDRA version: 9.1Level: PTClassification code 10050819Term: Musculoskeletal chest painEUCTR2008-003596-46-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
进行中（未招募）
不适用
An open-label, multicenter, study to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of three dosing regimens of oral AT2220 in patients with Pompe diseasePompe DiseaseEUCTR2008-002302-18-DEAmicus Therapeutics, Inc.18
进行中（未招募）
不适用
An open-label, multicenter, study to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of three dosing regimens of oral AT2220 in patients with Pompe diseaseMedDRA version: 9.1Level: LLTClassification code 10036143Term: Pompe's diseasePompe DiseaseEUCTR2008-002302-18-GBAmicus Therapeutics, Inc.18
已完成
不适用
[18F]THK-5351 PET Study of Normal, Mild Cognitive Impairment, Alzheimer’s Disease and Other Neurodegenerative DiseaseKCT0001785Asan Medical Center180
进行中（未招募）
不适用
An open-label, multi-center study to evaluate the efficacy of nilotinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and sunitinibEUCTR2008-000357-35-GBovartis Pharma GmbH